Biomedix Incubator (Israel) Probability of Future Stock Price Finishing Under 18210.0
| BMDX Stock | ILS 19,200 480.00 2.56% |
Biomedix |
Biomedix Incubator Target Price Odds to finish below 18210.0
The tendency of Biomedix Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to S 18,210 or more in 90 days |
| 19,200 | 90 days | 18,210 | about 47.18 |
Based on a normal probability distribution, the odds of Biomedix Incubator to drop to S 18,210 or more in 90 days from now is about 47.18 (This Biomedix Incubator probability density function shows the probability of Biomedix Stock to fall within a particular range of prices over 90 days) . Probability of Biomedix Incubator price to stay between S 18,210 and its current price of S19200.0 at the end of the 90-day period is about 15.94 .
Assuming the 90 days trading horizon Biomedix Incubator has a beta of 0.38 suggesting as returns on the market go up, Biomedix Incubator average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Biomedix Incubator will be expected to be much smaller as well. Additionally Biomedix Incubator has an alpha of 0.2101, implying that it can generate a 0.21 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Biomedix Incubator Price Density |
| Price |
Predictive Modules for Biomedix Incubator
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biomedix Incubator. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Biomedix Incubator Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Biomedix Incubator is not an exception. The market had few large corrections towards the Biomedix Incubator's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biomedix Incubator, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biomedix Incubator within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.21 | |
β | Beta against Dow Jones | 0.38 | |
σ | Overall volatility | 2,438 | |
Ir | Information ratio | 0.03 |
Biomedix Incubator Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biomedix Incubator for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biomedix Incubator can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biomedix Incubator had very high historical volatility over the last 90 days | |
| The company reported the revenue of 2 K. Net Loss for the year was (1.36 M) with loss before overhead, payroll, taxes, and interest of (39 K). | |
| Biomedix Incubator has accumulated about 5.71 M in cash with (1.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.1. |
Biomedix Incubator Technical Analysis
Biomedix Incubator's future price can be derived by breaking down and analyzing its technical indicators over time. Biomedix Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biomedix Incubator. In general, you should focus on analyzing Biomedix Stock price patterns and their correlations with different microeconomic environments and drivers.
Biomedix Incubator Predictive Forecast Models
Biomedix Incubator's time-series forecasting models is one of many Biomedix Incubator's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Biomedix Incubator's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Biomedix Incubator
Checking the ongoing alerts about Biomedix Incubator for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Biomedix Incubator help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Biomedix Incubator had very high historical volatility over the last 90 days | |
| The company reported the revenue of 2 K. Net Loss for the year was (1.36 M) with loss before overhead, payroll, taxes, and interest of (39 K). | |
| Biomedix Incubator has accumulated about 5.71 M in cash with (1.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.1. |
Other Information on Investing in Biomedix Stock
Biomedix Incubator financial ratios help investors to determine whether Biomedix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biomedix with respect to the benefits of owning Biomedix Incubator security.